Broad microbial surface structures and toxins

Broad microbial surface structures and toxins represent a heterogeneous class of molecules essential for the pathogenicity and survival of various microorganisms. This group includes structural components of the microbial cell wall, such as lipopolysaccharides (LPS) in Gram-negative bacteria and peptidoglycans in Gram-positive bacteria, as well as secreted exotoxins like hemolysins and pore-forming toxins [5, 8]. These molecules function as primary drivers of disease by facilitating host cell adhesion, disrupting membrane integrity, and overstimulating the host's innate immune system, often leading to systemic inflammation and sepsis [7, NIH]. Therapeutic interventions targeting these entities range from traditional antibiotics that inhibit cell wall synthesis to innovative anti-virulence agents like CAL02, which acts as a broad-spectrum decoy to sequester toxins [6, 9]. While these therapies are vital for managing severe infections, they carry risks such as the Jarisch-Herxheimer reaction, where the rapid release of microbial components triggers a potentially life-threatening inflammatory response [NIH].

Other names

Pathogen-associated molecular patterns (PAMPs)Microbial virulence factorsBacterial toxinsSurface antigensEndotoxins and Exotoxins

Drugs targeting these structures work through various mechanisms, including sequestration and neutralization of toxins (e.g., CAL02), disruption of the bacterial outer membrane (e.g., polymyxins), inhibition of cell wall synthesis (e.g., vancomycin), and competitive inhibition of toxin binding to host cell receptors (e.g., monoclonal antibodies) [5, 7, 8, NIH].